FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Maurer George R
2. Issuer Name and Ticker or Trading Symbol

ADOLOR CORP [ ADLR ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
SVP, Mfg. & Pharm Technologies
(Last)          (First)          (Middle)

700 PENNSYLVANIA DRIVE
3. Date of Earliest Transaction (MM/DD/YYYY)

12/7/2011
(Street)

EXTON, PA 19341
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Adolor Common Stock (ADLR)   12/7/2011     M    20715   A $3.83   181740   D    
Adolor Common Stock (ADLR)   12/7/2011     M    4285   A $3.83   186025   D    
Adolor Common Stock (ADLR)   12/7/2011     M    25520   A $4.23   211545   D    
Adolor Common Stock (ADLR)   12/7/2011     M    9480   A $4.23   221025   D    
Adolor Common Stock (ADLR)   12/7/2011     M    11978   A $1.77   233003   D    
Adolor Common Stock (ADLR)   12/7/2011     M    13022   A $1.77   246025   D    
Adolor Common Stock (ADLR)   12/7/2011     M    11979   A $1.77   258004   D    
Adolor Common Stock (ADLR)   12/7/2011     M    13021   A $1.77   271025   D    
Adolor Common Stock (ADLR)   12/7/2011     M    18718   A $1.34   289743   D    
Adolor Common Stock (ADLR)   12/7/2011     M    51282   A $1.34   341025   D    
Adolor Common Stock (ADLR)   12/7/2011     U    341025   D   (1) 0   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy)   $3.83   12/7/2011     M         20715      (2)   (2) Adolor Common Stock (ADLR)   20715   $ 0   0   D    
Stock Option (right to buy)   $3.83   12/7/2011     M         4285      (2)   (2) Adolor Common Stock (ADLR)   4285   $ 0   0   D    
Stock Option (right to buy)   $4.23   12/7/2011     M         25520      (2)   (2) Adolor Common Stock (ADLR)   25520   $ 0   0   D    
Stock Option (right to buy)   $4.23   12/7/2011     M         9480      (2)   (2) Adolor Common Stock (ADLR)   9480   $ 0   0   D    
Stock Option (right to buy)   $1.77   12/7/2011     M         11978      (2)   (2) Adolor Common Stock (ADLR)   11978   $ 0   0   D    
Stock Option (right to buy)   $1.77   12/7/2011     M         13022      (2)   (2) Adolor Common Stock (ADLR)   13022   $ 0   0   D    
Stock Option (right to buy)   $1.77   12/7/2011     M         11979      (2)   (2) Adolor Common Stock (ADLR)   11979   $ 0   0   D    
Stock Option (right to buy)   $1.77   12/7/2011     M         13021      (2)   (2) Adolor Common Stock (ADLR)   13021   $ 0   0   D    
Stock Option (right to buy)   $1.34   12/7/2011     M         18718      (2)   (2) Adolor Common Stock (ADLR)   18718   $ 0   0   D    
Stock Option (right to buy)   $1.34   12/7/2011     M         51582      (2)   (2) Adolor Common Stock (ADLR)   51582   $ 0   0   D    

Explanation of Responses:
( 1)  Shares are tendered pursuant to the tender offer commenced with respect to the Issuer's shares (the "Offer") at a purchase price of $4.25 per share in cash, plus one non-transferable contingent payment right for each share, which shall represent the right to receive up to $4.50 in cash subject to the fulfillment of certain conditions and/or the attainment of certain milestones, upon the terms and subject to the conditions set forth in the Offer.
( 2)  Transaction pertains to the vesting of unvested stock options and the issuance of shares of common stock underlying certain vested stock options, pursuant to the terms of the Agreement and Plan of Merger, dated as of October 24, 2011, by and among the Issuer, FRD Acquisition Corporation and Cubist Pharmaceuticals, Inc. and the related Offer.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Maurer George R
700 PENNSYLVANIA DRIVE
EXTON, PA 19341


SVP, Mfg. & Pharm Technologies

Signatures
/s/ George R. Maurer 12/8/2011
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Adolor Corp. (MM) (NASDAQ:ADLR)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024 Adolor Corp. (MM) 차트를 더 보려면 여기를 클릭.
Adolor Corp. (MM) (NASDAQ:ADLR)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024 Adolor Corp. (MM) 차트를 더 보려면 여기를 클릭.